The Roles of Antimicrobial Peptides in Innate Host Defense

被引:535
作者
Diamond, Gill [1 ]
Beckloff, Nicholas [1 ]
Weinberg, Aaron [2 ]
Kisich, Kevin O. [3 ]
机构
[1] UMDNJ, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07101 USA
[2] Case Western Reserve Univ, Dept Biol Sci, Sch Dent Med, Cleveland, OH 44106 USA
[3] Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA
关键词
Defensin; magainin; innate immunity; membrane disruption; GINGIVAL EPITHELIAL-CELLS; MESSENGER-RNA EXPRESSION; ANTIGEN-PRESENTING CELLS; HUMAN ALPHA-DEFENSINS; HUMAN BETA-DEFENSINS; RECEPTOR-LIKE; HUMAN BETA-DEFENSIN-2; DENDRITIC CELLS; STAPHYLOCOCCUS-AUREUS; PORE FORMATION;
D O I
10.2174/138161209788682325
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Antimicrobial peptides (AMPs) are multi-functional peptides whose fundamental biological role in vivo has been proposed to be the elimination of pathogenic microorganisms, including Gram-positive and -negative bacteria, fungi, and viruses. Genes encoding these peptides are expressed in a variety of cells in the host, including circulating phagocytic cells and mucosal epithelial cells, demonstrating a wide range of utility in the innate immune system. Expression of these genes is tightly regulated; they are induced by pathogens and cytokines as part of the host defense response, and they can be suppressed by bacterial virulence factors and environmental factors which can lead to increased susceptibility to infection. New research has also cast light on alternative functionalities, including immunomodulatory activities, which are related to their unique structural characteristics. These peptides represent not only an important component of innate host defense against microbial colonization and a link between innate and adaptive immunity, but also form a foundation for the development of new therapeutic agents.
引用
收藏
页码:2377 / 2392
页数:16
相关论文
共 246 条
[1]
Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro [J].
Aarbiou, J ;
Verhoosel, RM ;
van Wetering, S ;
de Boer, WI ;
van Krieken, JHJM ;
Litvinov, SV ;
Rabe, KF ;
Hiemstra, PS .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 30 (02) :193-201
[2]
Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167
[3]
Aerts A. M., 2008, CELL MOL LIFE SCI
[4]
ISOLATION OF 3 ANTIBACTERIAL PEPTIDES FROM PIG INTESTINE - GASTRIC-INHIBITORY POLYPEPTIDE(7-42), DIAZEPAM-BINDING INHIBITOR(32-86) AND A NOVEL FACTOR, PEPTIDE-3910 [J].
AGERBERTH, B ;
BOMAN, A ;
ANDERSSON, M ;
JORNVALL, H ;
MUTT, V ;
BOMAN, HG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 216 (02) :623-629
[5]
Antibacterial components in bronchoalveolar lavage fluid from healthy in individuals and sarcoidosis patients [J].
Agerberth, B ;
Grunewald, J ;
Castaños-Velez, E ;
Olsson, B ;
Jörnvall, H ;
Wigzell, H ;
Eklund, A ;
Gudmundsson, GH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) :283-290
[6]
The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations [J].
Agerberth, B ;
Charo, J ;
Werr, J ;
Olsson, B ;
Idali, F ;
Lindbom, L ;
Kiessling, R ;
Jörnvall, H ;
Wigzell, H ;
Gudmundsson, GH .
BLOOD, 2000, 96 (09) :3086-3093
[7]
Impairment of innate immune responses of airway epithelium by infection with bovine viral diarrhea virus [J].
Al-Haddawi, A. ;
Mitchell, G. B. ;
Clark, M. E. ;
Wood, R. D. ;
Caswell, J. L. .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2007, 116 (3-4) :153-162
[8]
IL-4 and IL-13 negatively regulate TNF-α- and IFN-γ-induced β-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3 [J].
Albanesi, Cristina ;
Fairchild, Heather R. ;
Madonna, Stefania ;
Scarponi, Claudia ;
De Pita, Ornella ;
Leung, Donald Y. M. ;
Howell, Michael D. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (02) :984-992
[9]
Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems [J].
Angot, Aurelie ;
Vergunst, Annette ;
Genin, Stephane ;
Peeters, Nemo .
PLOS PATHOGENS, 2007, 3 (01) :1-13
[10]
Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297